Board of Directors  arrow.gif
Executive Council  arrow.gif
Contact us  arrow.gif
OMICS arrow.gif

DAVID J. ARPASI

David J. Arpasi is the President of In-Red Services Corporation, a firm which provides tax consultation and tax preparation services along with other traditional finance and accounting services. Mr. Arpasi was awarded an M.B.A. in Finance and Business Management from Indiana University and also holds a B.S. in Business from Indiana University. He was elected to membership in Beta Gamma Sigma. Prior to developing his own corporation, Mr. Arpasi was a senior financial manager for three major corporations as well as a veteran of the United States Air Force. He has been involved with BIATECH since its inception providing tax, finance, and accounting expertise.

EUGENE KOLKER

Until 2002 Dr. Kolker was Computation Biology Lead at ISB, and recently Eugene became the Affiliate Associate Professor at the University of Washington. In 2002, Dr. Kolker started BIATECH and serves as its President and Director. Dr. Kolker has extensive computational and molecular biology experience on genomics and proteomics, statistical and algorithmic development, data analysis and integration and has been a member of the Board of Directors for the International Society for Computational Biology. In 2001 he was invited to and accepted the position of Editor-in-Chief of a new journal "OMICS A Journal of Integrative Biology". Dr. Kolker serves as a Head of the Board of Directors.
     More details

HENRY G. LIEBMAN

President, founder, and co-owner of American Life, Mr. Henry G. Liebman has over twenty years experience in immigration, real estate, and recently biotechnology-related law as Managing Partner of Coe Nordwall Liebman LLC and currently at Liebman-Mimbu PLLC. Mr. Liebman is the author of several books on immigration law and was the founder of Northwest International Bank, serving as the bank's first Chairman of the Board and now as a director and Loan Committee member. His experience in purchasing, managing the development of commercial-industrial properties and biotechnology startups, coupled with his banking and investment experience, has given Mr. Liebman his unique business background. This unusual depth of skill in business, finance, and law, especially in biotechnology-related issues, is invaluable to BIATECH. Mr. Liebman currently serves as BIATECH's Secretary.